Immune phenotyping of lymphoid compartments revealed that bardoxolone methyl administration led to a relative depletion of CD4+ T cells in the spleen, accompanied by a marked enrichment of CD8+ T cells within both the spleen and tumor microenvironment. The gene discussed is CD4; the disease is neoplasm.